Display options
Share it on

Chem Cent J. 2014 Dec 17;8:74. doi: 10.1186/s13065-014-0074-z. eCollection 2014.

Regioselective synthesis of 2-(bromomethyl)-5-aryl-thiophene derivatives via palladium (0) catalyzed suzuki cross-coupling reactions: as antithrombotic and haemolytically active molecules.

Chemistry Central journal

Komal Rizwan, Muhammad Zubair, Nasir Rasool, Shaukat Ali, Ameer Fawad Zahoor, Usman Ali Rana, Salah Ud-Din Khan, Muhammad Shahid, Muhammad Zia-Ul-Haq, Hawa Ze Jaafar

Affiliations

  1. Department of Chemistry, Government College University, Faisalabad, 38000 Pakistan.
  2. Sustainable Energy Technologies (SET) Center, College of Engineering, King Saud University, PO-Box?-?800, Riyadh, 11421 Saudi Arabia.
  3. Department of Chemistry and Biochemistry, University of Agriculture, Faisalabad, 38040 Pakistan.
  4. The Patent Office, Karachi, Pakistan.
  5. Department of Crop Science, Faculty of Agriculture, 43400 UPM Serdang, Selangor Malaysia.

PMID: 25685184 PMCID: PMC4326645 DOI: 10.1186/s13065-014-0074-z

Abstract

BACKGROUND: It is seen that the regioselective functionalizations of halogenated heterocycles play an important role in the synthesis of several types of organic compounds. In this domain, the Suzuki-Miyaura reaction has emerged as a convenient way to build carbon-carbon bonds in synthesizing organic compounds. Some of the most important applications of these reactions can be seen in the synthesis of natural products, and in designing targeted pharmaceutical compounds. Herein, we present the regioselective synthesis of the novel series of 2-(bromomethyl)-5-aryl-thiophenes 3a-i, via Suzuki cross-coupling reactions of various aryl boronic acids with 2-bromo-5-(bromomethyl)thiophene (2).

RESULTS: The synthesized compounds were screened for their haemolytic and antithrombolytic activities. The novel compounds 3f, 3i showed highest 69.7, 33.6% haemolysis of blood cells, respectively. The antithrombolytic activity of the compounds was found to be within low to moderate against human blood clot. The compound 3i showed potent clot lysis (31.5%).

CONCLUSIONS: Considering these results, it is concluded that the synthesized compounds can be used as a promising source of therapeutic agents.

Keywords: Antithrombotic; Aryl boronic acid; Cytotoxicity; Haemolytic; Heterocycles; Palladium; Suzuki cross-coupling reactions; Thiophene

References

  1. Drugs. 1997 Nov;54(5):745-50; discussion 751 - PubMed
  2. J Med Chem. 1984 Apr;27(4):528-30 - PubMed
  3. Int J Biol Macromol. 2013 Nov;62:172-9 - PubMed
  4. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):398-9 - PubMed
  5. Bioorg Med Chem. 2001 Aug;9(8):1977-84 - PubMed
  6. Eur J Med Chem. 2009 Jan;44(1):63-9 - PubMed
  7. Science. 1994 Sep 16;265(5179):1684-6 - PubMed
  8. Acta Pharm. 2008 Mar;58(1):1-14 - PubMed
  9. J Med Chem. 2008 Sep 25;51(18):5522-32 - PubMed
  10. J Org Chem. 2006 Nov 24;71(24):9198-202 - PubMed
  11. J Med Chem. 1988 Sep;31(9):1786-93 - PubMed
  12. Eur J Med Chem. 2005 Dec;40(12):1414-9 - PubMed
  13. Bioorg Med Chem. 2010 Feb 15;18(4):1482-96 - PubMed
  14. BMJ. 1995 Dec 2;311(7018):1506 - PubMed
  15. Thromb J. 2006 Sep 12;4:14 - PubMed
  16. Molecules. 2013 Nov 27;18(12):14711-25 - PubMed
  17. Bioorg Med Chem. 2009 Oct 1;17(19):6796-802 - PubMed
  18. Tetrahedron Lett. 2011 Oct 26;52(43):5656-5658 - PubMed
  19. J Physiol Pharmacol. 2002 Dec;53(4 Pt 1):625-34 - PubMed
  20. J Med Chem. 2005 Sep 22;48(19):5900-8 - PubMed
  21. Postgrad Med J. 2000 Jan;76(891):12-5 - PubMed
  22. Med Chem. 2007 Jan;3(1):67-73 - PubMed
  23. Ann Intern Med. 1990 Apr 1;112(7):529-38 - PubMed
  24. Haemostasis. 1983;13 Suppl 1:1-54 - PubMed
  25. Science. 1995 Apr 14;268(5208):270-1 - PubMed
  26. Molecules. 2012 Apr 23;17(4):4703-16 - PubMed

Publication Types